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Abstract The regulators of G-protein signaling (RGS) family
members contain a conserved region, the RGS domain, and are
GTPase-activating proteins for many members of G-protein K-
subunits. We report here that the core domain of RGS16 is
sufficient for in vitro biochemical functions as assayed by its G-
protein binding affinity and its ability to stimulate GTP
hydrolysis by GKo protein. RGS16 also requires, in addition to
the RGS domain, the divergent N-terminus for its biological
function in the attenuation of pheromone signaling in yeast,
whereas its C-terminus region is dispensable. Together with other
evidence, these data support the notion that RGS proteins
interact with other cellular factors and may serve to link specific
G-proteins to different downstream effectors in G-protein-
mediated signaling pathways.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The regulators of G-protein signaling (RGS), de¢ned by
initial genetic studies as negative regulators of G-protein-
mediated signaling, have been demonstrated to serve as
GTPase-activating proteins (GAP) of a variety of G-protein
K-subunits, thus terminating the signaling process by G-pro-
tein-coupled receptors [1^5]. The RGS proteins share an evo-
lutionarily conserved domain of approximately 120 amino
acid residues, referred to as the RGS domain. The RGS pro-
teins bind to GK subunits with high a⁄nity in the presence of
both GDP and AlF34 , suggesting that they accelerate GTP
hydrolysis by stabilizing the GTPase transition state [6].
This is supported by evidence obtained from crystallographic
studies [7]. We have previously identi¢ed and characterized
RGS16 (also known as RGS-r [8]) and shown that RGS16
binds GK subunits in the transition state [9]. However, RGS16
also binds G-proteins with signi¢cantly high a⁄nity in the
presence of GDP alone [9]. The signi¢cance of RGS binding
to the inactive state of GK is unclear. It is possible that in
addition to GAP activity, some of the RGS proteins may also
modulate G-protein reactivation, or the RGS-GK(GDP) com-
plex may have downstream e¡ectors.
Alignment of RGS proteins reveals that they contain diver-
gent sequences £anking the conserved RGS domain. Further-
more, they have a striking size variation ranging from 21 to
150 kDa [4,5,10]. In view of their diversity, RGS proteins may
not only serve as GTPase-activating proteins, but could also
be interacting with a diverse number of cellular proteins that
may play crucial roles in G-protein-mediated signal transduc-
tion. Indeed, D-AKAP-2, a recently identi¢ed protein that
binds to both type-I and type-II regulatory subunits of
cAMP-dependent protein kinase (PKA), possesses an RGS
domain, with the R-subunit-binding fragment at its divergent
C-terminus [11]. RGS proteins may therefore play a direct
role in the regulation of a signaling pathway that is commonly
believed to be regulated by intracellular levels of the second
messenger cAMP, primarily controlled by the Gs subunit. In
addition, we have previously noticed that a short deletion of
the N-terminus of RGS16 resulted in the loss of its biological
activity although its G-protein binding capacity was intact.
The size heterogeneity in the divergent sequences amongst
the RGS protein family members further prompted us to
study the structural requirements for the biochemical and bio-
logical functions of these proteins. In this report we show that
the core RGS16 domain retains full GTPase activation activ-
ity and G-protein binding activity as assayed using several G
subunits, including GKo, but the divergent N-terminus is re-
quired for its physiological function.
2. Materials and methods
2.1. Construction of RGS16 deletion mutants
cDNA fragments for RGS16 deletion mutants were generated by
polymerase chain reactions (PCR). The 5P sense oligonucleotide pri-
mers used to create three RGS16 N-terminal deletion mutants, vN13,
vN23, and vN55, were CCATGGAGAGAGCTAAAGAGTT-
CAAG, CCATGGGAATCTTTCTTCATAAATCA, and CCATG-
GAAGATGTACTGGGATGGAGA, respectively, each including an
NcoI site. The 3P antisense oligonucleotide common for the three
mutants was CGGAGGCTCAAGTGTGTGAAGGCT. The 5P oligo-
nucleotide common for C-terminal deletion mutants vC16, vC34, and
vC41, was CTCGAGATGTGCCGCACCCTAGCCACCTTC. The
corresponding antisense primers were: GATTAGGCCGAGGCTTG-
GGCAGCC, CGTTAATAGGAGTCCTTCTCCATC, and ATCTA-
TGTGCGGGTCTTCCCCTGA, respectively. The sense primer of
vN55 and the antisense primer of vC16 were used to generate the
core RGS domain, vN55vC16. The PCR products were treated with
Klenow DNA polymerase and polynucleotide kinase, and ligated to
the SmaI site of pBluescript (Stratagene) for sequencing analysis.
2.2. GTPase-activating activity assays
The GKo protein cDNA, generated by PCR as previously described
[9], was ligated to the plasmid pQE30 (Qiagen). Wild type RGS16,
vC16, vC34, and vC41 cDNA fragments in pBluescript were released
with XhoI and BamHI, blunt-ended with Klenow polymerase, and
ligated to SphI/Klenow-treated pQE30 vector. The cDNA fragments
for vN13, vN23, vN55, and vN55vC16 cDNAs were released with
NcoI/BamHI, blunt-ended with Klenow, and ligated to BamHI/Kle-
now-treated pQE30 plasmid. The ligation reactions were separately
transformed into the bacterial strain M15 and transformants express-
ing individual protein were rapidly screened for from small-scale ex-
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pression cultures according to the manufacturer’s instructions (Qia-
gen). Eluted protein samples were dialyzed in the elution bu¡er with-
out imidazole. Protein concentrations were determined using the Bio-
Rad protein assay (Bio-Rad).
The GAP activities of each RGS16 protein were determined as
previously described [12]. Brie£y, 0.25 WM GKo was incubated with
[Q-32P]GTP (1 WM) in a bu¡er containing 50 mM Na-HEPES (pH
8.0), 5 mM EDTA, 0.05% C12E10, and 2 mM DTT, at 30‡C for 30
min; the temperature was then lowered to 10‡C. A 5 Wl aliquot of
mixture was added into 15 Wl reaction bu¡er containing 50 mM Na-
HEPES (pH 8.0), 0.05% C12E10, 100 WM unlabeled GTP and 2 mM
DTT at 0‡C. This was the zero timepoint. 40 Wl of GTP-preloaded
GKo mixture was then added into 120 Wl reaction bu¡er supplemented
with MgSO4 (12 WM ¢nal concentration) and indicated RGS protein
(2 WM ¢nal concentration) or bu¡er to initiate GTP hydrolysis. 15 Wl
aliquots were removed at the indicated timepoints and dotted onto
BA85 ¢lter discs kept on an ice-cold NUNC-Bio assay plate. After
washing at 0‡C in PBS bu¡er supplemented with 10 mM EDTA,
¢lters containing residual unhydrolyzed GTP on GKo were subjected
to liquid scintillation spectrometry.
2.3. RGS-G-protein binding assays
The wild type RGS16 and three C-terminal deletion cDNAs were
fused in-frame to the XhoI site of a derivative of the bacterial expres-
sion vector pGex2TK (Pharmacia). The cDNA fragments for the
three N-terminal deletion mutants and the core RGS domain were
released from pBluescript constructs with NcoI/BamHI, and treated
with Klenow. The blunt-ended fragments were then fused in-frame to
the XhoI site (blunt-ended by Klenow) of the derivative vector. The
fusion proteins were expressed in the Escherichia coli strain
BL21(DE3)-pLysS and puri¢ed as GST-fusion proteins as described
before [9]. The G-proteins (GKi3, GKi2, and GKo) were generated and
35S-labeled by in vitro transcription and translation reactions using
TNT coupled reticulocyte lysate systems (Promega) and
[35S]methionine. Deletion mutant proteins were assayed for their bind-
ing to G-proteins in the same way as previously described [9].
2.4. Pheromone response assay
The yeast expression construct in the pMW29 vector encoding the
wild type RGS16 was as previously described [9]. The fragments of
individual RGS16 deletion mutant cDNAs were released with EcoRV/
BamHI from the pBluescript constructs and cloned into SmaI/BamHI
sites of pMW29, a yeast expression vector under the control of a
galactose-inducible promoter [13]. The biological function of RGS16
deletion mutants was analyzed by a bioassay measuring the sensitivity
of pheromone response in US356 yeast cells as previously described
[9]. To monitor expression levels of each RGS16 construct, Western
blotting analysis was performed as previously described [9], using
a⁄nity-puri¢ed speci¢c antibody raised against full-length RGS16
protein.
3. Results
3.1. The core RGS16 domain retains full G-protein
binding activity
To assess the minimum sequence requirement for the func-
tion of RGS16, we generated a series of deletion mutant con-
structs as schematically diagrammed in Fig. 1. These mutant
proteins were expressed as GST-fusion proteins in E. coli and
a⁄nity-puri¢ed with glutathione-agarose. G-proteins, GKo,
GKi2, GKi3, were generated and 35S-labeled by in vitro tran-
scription and translation. The GST-fusion RGS proteins were
¢rst analyzed for their binding e⁄ciency to the G-proteins. As
shown previously [8,9], the wild type RGS16 protein binds
strongly to the G-proteins in the presence of both GDP and
AlF34 . It also binds the G-proteins in the presence of GDP
alone [9], albeit to a lesser extent (Fig. 2A^C). Whereas all the
deletion mutants that included the core RGS domain (vN13,
vN23, vN55, vN55vC16, vC16) bound to the G-proteins
with the same a⁄nity as that of the wild type RGS16 (Fig.
2), a short deletion of the core RGS region (vC34) completely
abolished its G-protein binding a⁄nity (Fig. 2B).
3.2. The divergent regions are not required for GAP activity
We further examined the structural requirement of RGS16
function by measuring the GAP activity of the various
deletion mutants on one of the G-proteins, GKo. The ability
of the di¡erent RGS mutants to a¡ect the GTP hydrolysis
by GKo was tested using a one-round hydrolysis assay with
[Q-32P]GTP as substrate. The [32Pi] released was calculated by
subtracting remaining counts at an indicated time from 32P
counts on ¢lters at zero timepoint. In the absence of RGS, the
kcat for GKo to hydrolyze GTP was 0.014 s31 at 10‡C (Fig.
3A,B). In the presence of wild type RGS16, the reaction was
completed at the earliest timepoint (8 s) ; GTP hydrolysis was
accelerated approximately seven-fold with a catalytic constant
(kcat) of 0.10 s31 (Fig. 3A,B). The N-terminal deletion mu-
tants (vN13, vN23, vN55) and C-terminal deletion mutants
outside the RGS domain (vC16) also stimulated the GTPase
activity of GKo at levels similar to that by wild type RGS16
(Fig. 3A,B). Similarly, the core RGS domain mutant,
vN55vC16, retained the GAP activity with a kcat of 0.096
s31 (Fig. 3B). However, two C-terminal deletion mutants
(vC34 and vC41) with some conserved amino acid residues
in the RGS domain removed, failed to activate GTP hydrol-
ysis and did not have obviously distinguishable kinetics from
GKo alone (Fig. 3B, and data not shown). These observations
indicate that the divergent sequences £anking the core domain
are not required for the GAP activity of RGS16, and that the
GAP activity of RGS16 needs its full RGS domain.
3.3. An intact N-terminus is critical for RGS16 biological
activity
As the deletion mutants containing the RGS domain re-
tained both the G-protein binding a⁄nity and GAP activity
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Fig. 1. Schematic diagram of the RGS16 full-length and deletion constructs. The names of di¡erent constructs are shown on the left; numbers
at the top of each bar indicate the amino acid positions of the start and end of each construct, with respect to the wild type RGS16.
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on GKo in vitro, we tested their biological functions taking
advantage of the fact that wild type RGS16 functionally re-
sembles the yeast RGS protein Sst2p to attenuate pheromone
signaling [2,9]. The biological function assay was performed
by transforming di¡erent RGS16 pMW29 constructs into the
yeast strain US356 that harbors a mutation in the bar1 gene
encoding a secreted protease capable of cleaving K-factor. In
the absence of overexpressed RGS16, the yeast cells form a
clear halo corresponding to the area of growth arrest. As
previously shown [9], the RGS16 overexpressing yeast trans-
formants are no longer sensitive to the pheromone factor (Fig.
4A,B). A short deletion of the N-terminus (vN13) completely
abolished the attenuating e¡ect on pheromone signaling. Fur-
ther deletion mutants of the N-terminus (vN23, vN55) be-
haved similarly (Fig. 4A). All the mutant cDNA constructs
resulted in comparable levels of expression to those of the
wild type RGS16, indicating the functional di¡erence between
the wild type RGS16 and its mutants is not due to impairment
of expression. Relevance of the bioassay in yeast is supported
by our recent ¢nding that perturbation by fusion of a FLAG
tag to the N-terminus diminished RGS16 function in a cell
growth assay in Chinese hamster ovary cells (Zhang and Lin,
unpublished observation).
3.4. The vC16 mutation retains both GAP activity and
pheromone attenuation functions
In contrast to what was observed in the deletion mutants of
the N-terminus, removal of the C-terminus (vC16) did not
a¡ect the functions of RGS16. Compared to the wild type
RGS16, vC16 binds equally well to all the three G-proteins
analyzed, Gao, GKi2, GKi3 (Fig. 2B), and as mentioned above,
it retains full GAP activity on Gao (Fig. 3B). Similarly, in the
yeast bioassay, vC16 suppressed the pheromone sensitivity of
US356 cells, as does the wild type RGS16. Further deletion in
the conserved region (vC34, v41) destroyed both the G-pro-
tein binding and pheromone attenuation activity (Fig. 2B,
Fig. 4B, and data not shown).
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Fig. 3. GTPase-activating protein activity of various RGS16 pro-
teins on GKo. Relative GAP activities on GKo of the N-terminal de-
letion mutants (vN13, vN23, vN55), and C-terminal mutants
(vC16, vC34), the core RGS domain (vN55vC16), as well as the
wild type RGS16, are shown in panels A and B, respectively.
Fig. 2. Binding assays of RGS16 deletion mutants to GK proteins.
The relative binding a⁄nities of the N-terminal deletion mutants, C-
terminal deletion mutants, and the core RGS domain of RGS16 to
G-proteins are shown in panels A, B, and C, respectively. Recombi-
nant RGS16 proteins and GST as a control (indicated at the top of
each panel) were incubated separately with individual G-proteins
(indicated on the left) pre-incubated with GDP or GDP plus AlF34 .
After washing, the beads were boiled with the SDS protein sample
bu¡er and the eluted proteins were resolved on SDS-PAGE gels,
along with the total input of each labeled G-protein (the ¢rst lane
of each panel). The gels were stained with Coomassie blue, dried,
and were exposed to X-ray ¢lms. Shown at the bottom of each pan-
el is a representative SDS-PAGE gel stained with Coomassie blue,
indicating relative GST-fusion RGS protein inputs.
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4. Discussion
We have described in this report that the core domain of
RGS16 retains GTPase-activating protein activity on GKo in
vitro that is virtually indistinguishable from that of the full-
length protein. Our results obtained with RGS16 are consis-
tent with the crystallographic studies showing that only the
RGS domain residues are in contact with G-proteins [7], and
that the core domains of other RGS proteins such as the
retina-speci¢c RET-RGS1, RGS4, retain full GAP activities
on G-proteins [14,15]. We further show that the core RGS16
domain binds equally well to the G-proteins, Gao, GKi2, GKi3,
providing an explanation for the full GAP activity of the core
domains of RGS proteins.
However, bioassays based on the ability to attenuate pher-
omone signaling in yeast show that RGS16 needs an intact N-
terminus to function. In contrast, removal of 16 amino acid
residues from the C-terminus did not a¡ect either the in vitro
biochemical or in vivo functions. The biological relevance of
the bioassay is further supported by other evidence showing
that fusion of a FLAG tag to the N-terminus of full-length
RGS16 diminished its in vivo function in modulating cell
growth (Zhang and Lin, unpublished results). Similar to
what we observed in the bioassay using the C-terminal dele-
tion mutants, the tagging to the C-terminus did not a¡ect
RGS16 activity in the cell growth assays. Furthermore, it
should be noted that the deletions of the N-terminus or the
C-terminus did not cause protein misfolding or alteration of
protein stability as no obvious change in protein expression
levels or solubility of deletion mutant proteins was observed
in either bacterial cells, yeast cells, or CHO cells. How the
divergent N-terminal and C-terminal regions modulate the
function of RGS proteins remains to be further studied.
One study with the GAIP (GK interacting protein) RGS pro-
tein suggests that palmitoylation may be involved in the sub-
cellular localization and function in membrane tra⁄cking of
GAIP [16,17]. However, RGS16 does not have the consensus
sequence for such a modi¢cation. The recent identi¢cation of
D-AKAP-2 that binds to the regulatory subunits of PKA
suggests an exciting possibility that there exist a variety of
cellular factors that bind to the divergent regions of RGS
proteins [11]. These proteins may link di¡erent G-proteins
to speci¢c downstream e¡ectors. Identi¢cation and character-
ization of putative cellular factors that bind to the N-terminus
of RGS16 is under way.
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Fig. 4. Yeast pheromone response assays. Halo assays of the N-ter-
minal deletion mutants and C-terminal deletion mutants are shown
in panels A and B, respectively. The arrangement of each dish is di-
agrammed at the top right; the expression levels of each RGS16
protein, accessed by Western analysis using anti-RGS16 antibody,
are indicated at the bottom right.
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